Long-term complications of type 1 diabetes: what do we know and what do we need to understand?


Journal

Minerva pediatrics
ISSN: 2724-5780
Titre abrégé: Minerva Pediatr (Torino)
Pays: Italy
ID NLM: 101777303

Informations de publication

Date de publication:
Dec 2021
Historique:
pubmed: 18 9 2021
medline: 13 1 2022
entrez: 17 9 2021
Statut: ppublish

Résumé

Long-term complications of type 1 diabetes (T1D) include microvascular complications and macrovascular disease. Despite the important advances in the treatment of T1D of the last decades, these complications still represent the leading cause of morbidity and mortality in patients with T1D. Extensive evidence indicates that structural and functional alterations of the kidney, retina, nerves and large arteries occur already in the first years after the onset of diabetes. We performed a comprehensive review of the available evidence on screening, diagnosis, prevention and treatment of vascular complications of T1D. In particular, we focused on three major challenges related to long-term complications of T1D: 1) finding of new biomarkers and diagnostic methods able to identify early signs of complications; 2) identifying specific risk factors for the development of these complications; 3) identifying and implementing new therapeutic strategies able to prevent the development and progression of vascular complications.

Identifiants

pubmed: 34530587
pii: S2724-5276.21.06545-9
doi: 10.23736/S2724-5276.21.06545-9
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

504-522

Auteurs

Claudia Piona (C)

Pediatric Diabetes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, University City Hospital, Verona, Italy.

Claudia Ventrici (C)

Pediatric Unit, Hospital of Polistena, Reggio Calabria, Italy.

Loredana Marcovecchio (L)

Department of Pediatrics, University of Cambridge, Cambridge, UK.

Francesco Chiarelli (F)

Department of Pediatrics, University of Chieti, Chieti, Italy.

Claudio Maffeis (C)

Pediatric Diabetes and Metabolic Disorders Unit, Regional Center for Pediatric Diabetes, University City Hospital, Verona, Italy.

Riccardo Bonfanti (R)

Diabetes Research Institute, Department of Pediatrics, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Ivana Rabbone (I)

Division of Pediatrics, Department of Health Sciences, University of Eastern Piedmont, Novara, Italy - ivana.rabbone@uniupo.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH